Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors’ Expert Forum

In December 2008, the U.S. Food and Drug Administration issued guidance to the pharmaceutical industry setting new expectations for the development of antidiabetes drugs for type 2 diabetes. This guidance expanded the scope and cost of research necessary for approval of such drugs by mandating long-...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes Care
Main Authors: Cefalu, William T., Kaul, Sanjay, Gerstein, Hertzel C., Holman, Rury R., Zinman, Bernard, Skyler, Jay S., Green, Jennifer B., Buse, John B., Inzucchi, Silvio E., Leiter, Lawrence A., Raz, Itamar, Rosenstock, Julio, Riddle, Matthew C.
Format: Artigo
Language:Inglês
Published: American Diabetes Association 2018
Subjects:
Diabetes Care Expert Forum
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5741160/
https://ncbi.nlm.nih.gov/pubmed/29263194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dci17-0057
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items